Abstract
To validate the accuracy of previously published US seroprevalence estimates for hepatitis D virus (HDV) antibody, we retested National Health and Nutrition Examination Survey samples from 2007 to 2018 using a different assay. We found the HDV seroprevalence among hepatitis B surface antigen-positive participants aged ≥6 years to be 1.26%.
Funding Information
  • Centers for Disease Control and Prevention
  • U.S. Department of Health and Human Services

This publication has 12 references indexed in Scilit: